Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Sichuan Biokin Pharmaceutical (688506 CH)
Watchlist
22
Analysis
Health Care
•
China
Sichuan Biokin Pharmaceutical Co.,Ltd. operates as a pharmaceutical company. The Company produces children's medicine, cardiovascular drugs, anesthetics, chronic disease drugs, and more. Sichuan Biokin Pharmaceutical conducts businesses worldwide.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Suzhou Novosense Microelectron
•
01 Feb 2024 07:18
STAR50 Index Rebalance Preview: Sustaining Outperformance on Expected Impact
There could be 3 changes for the STAR50 Index in March. One-way turnover is estimated at 2.4% leading to a one-way trade of CNY 2.9bn. The...
Brian Freitas
Follow
557 Views
Share
bearish
•
Remegen
•
23 Jan 2024 08:55
Remegen (9995.HK/688331.CH) - The Real Reasons for the Stock Price Collapse and the Future Prospects
RemeGen's 23Q4 results will miss expectation, leading to poor performance for 2023.The pain point isn't cashflow shortage but weak...
Xinyao (Criss) Wang
Follow
300 Views
Share
bullish
•
Thematic (Sector/Industry)
•
02 Jan 2024 08:55
China's Rising Role in Global ADC Partnership Wave - Opportunities and Risks Behind the Gold Rush
As China's ADCs continue to gain recognition from global buyers,the position of Chinese pharmaceutical companies is undergoing fundamental...
Xinyao (Criss) Wang
Follow
485 Views
Share
bullish
•
Nexchip Semiconductor
•
21 Dec 2023 06:20
STAR50 Index Rebalance Preview: Four High Impact Changes in March
There could be 4 changes for the STAR50 Index in March. Passive trackers will need to trade between 1.2-9.7x ADV on the adds/dels. There will be...
Brian Freitas
Follow
758 Views
Share
bearish
•
Shanghai Haoyuan Chemexpress C
•
17 Dec 2023 09:21
China Healthcare Weekly (Dec.15)-BMS/Biokin $8.4B Eye-Popping Deal, NRDL Negotiation Result, Haoyuan
2023 NRDL negotiation result is released, policy for innovative drugs become more friendly. BMS-Biokin $8.4B deal is record-breaking, but with...
Xinyao (Criss) Wang
Follow
469 Views
Share
First
Previous
1
2
3
4
5
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x